EUVIMEDEUVIMED entdecken
Crossref

Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory

Wei Lin, Anyin Li, Lin Qiu, Hai Huang iD, Pengfei Cui iD, Jianhao Wang iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Wei Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Petroleum and Chemical Engineering, Changzhou University, Changzhou 213164, P. R. China. Hauptthemen laut MEDLINE: Doxorubicin, Nanoparticles, Polyethylene Glycols. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Government of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most significant reasons hindering the clinical translation of nanomedicines is the rapid clearance of intravenously injected nanoparticles by the mononuclear phagocyte system, particularly by Kupffer cells in the liver, leading to an inefficient delivery of nanomedicines for tumor treatment. The threshold theory suggests that the liver's capacity to clear nanoparticles is limited, and a single high dose of nanoparticles can reduce the hepatic clearance efficiency, allowing more nanomedicines to reach tumor tissues and enhance therapeutic efficacy. Building upon this theory, researchers have conducted numerous validation studies based on the same nanoparticle carrier systems. These studies involve the use of albumin nanoparticles to improve the therapeutic efficacy of albumin nanomedicines as well as polyethylene glycol (PEG)-modified liposomal nanoparticles to enhance the efficacy of PEGylated liposomal nanomedicines. However, there is no research indicating the feasibility of the threshold theory when blank nanoparticles and nanomedicine belong to different nanoparticle carrier systems currently. In this study, we prepared two different sizes of albumin nanoparticles by using bovine serum albumin. We used the marketed nanomedicine liposomal doxorubicin hydrochloride injection (trade name: LIBOD, manufacturer: Shanghai Fudan-zhangjiang Biopharmaceutical Co., Ltd.), as the representative nanomedicine. Through in vivo experiments, we found that using threshold doses of albumin nanoparticles still can reduce the clearance rate of LIBOD, prolong its time in vivo, increase the area under the plasma concentration-time curve (AUC), and also lead to an increased accumulation of the drug at the tumor site. Furthermore, evaluation of in vivo efficacy and safety further indicates that threshold doses of 100 nm albumin nanoparticles can enhance the antitumor effect of LIBOD without causing harm to the animals. During the study, we found that the particle size of albumin nanoparticles influenced the in vivo distribution of the nanomedicine at the same threshold dose. Compared with 200 nm albumin nanoparticles, 100 nm albumin nanoparticles more effectively reduce the clearance efficiency of LIBOD and enhance nanomedicine accumulation at the tumor site, warranting further investigation. This study utilized albumin nanoparticles to reduce hepatic clearance efficiency and enhance the delivery efficiency of nonalbumin nanocarrier liposomal nanomedicine, providing a new avenue to improve the efficacy and clinical translation of nanomedicines with different carrier systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinNanoparticlesPolyethylene GlycolsAnimalsMiceLiposomesSerum Albumin, BovineTissue DistributionAntibiotics, AntineoplasticMice, Inbred BALB CLiverParticle SizeNanomedicineHumansMaleFemale

Stichwörter der Autor:innen

albumin nanoparticlesdoxorubicin hydrochloride liposome injectionthreshold theory

Substanzen

Doxorubicinliposomal doxorubicinPolyethylene GlycolsLiposomesSerum Albumin, BovineAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Petroleum and Chemical Engineering, Changzhou University, Changzhou 213164, P. R. China.
  • School of Pharmacy, Changzhou University, Changzhou 213164, P. R. China.

ORCID-Profile: Hai Huang, Pengfei Cui, Jianhao Wang

Förderung

  • National Key Research and Development Program of China
  • Government of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Lin, W., Li, A., Qiu, L., Huang, H., Cui, P., & Wang, J. (2024). Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00097

Vancouver

Lin W, Li A, Qiu L, Huang H, Cui P, Wang J. Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00097

BibTeX
@article{Lin2024,
  author = {Lin, Wei and Li, Anyin and Qiu, Lin and Huang, Hai and Cui, Pengfei and Wang, Jianhao},
  title = {Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00097}
}
Kostenlos starten →